Epigenetic Cancer Therapy

Epigenetic Cancer Therapy by Steven Gray

Epigenetic Cancer Therapy, Second Edition provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with new discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental initiatives, as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Since the publication of the first edition of this book, the field of epigenetics has undergone significant change. New epigenetic therapies have been designed and approved for clinical use. Our knowledge of the plasticity of the epigenome in cancer and disease has expanded dramatically, with increasing evidence linking pollution to epigenetic changes in cancer development. This second edition has been fully updated to address these changes, along with promising therapeutic programs such as CRISPR/Cas9 mediated approaches, CAR-T based therapies, epigenetic priming, histone modifications, and similar, transformative advances across synthetic biology and cellular engineering.

Steven Gray is a Senior Clinical Scientist and Adjunct Assistant Professor in the Thoracic Oncology Research Group, Trinity Centre for Health Sciences at St. James's Hospital, Dublin, Ireland.

SKU	Unavailable
ISBN 13	9780323913676
ISBN 10	0323913679
Title	Epigenetic Cancer Therapy
Author	Steven Gray
Series	Translational Epigenetics
Condition	Unavailable
Binding Type	Paperback
Publisher	Elsevier Science & Technology
Year published	2023-05-03
Number of pages	772
Cover note	Book picture is for illustrative purposes only, actual binding, cover or edition may vary.